Innate Pharma SA IPHA

Latest FY: 2025 Healthcare Biotechnology
Market Price $2.11
Market Cap $197.75M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-55.2% YoY
$9.02M
3-Yr CAGR: -46.1%
Net Income ↑0.6% YoY
-$49.18M
Net Margin: -545.3%
Free Cash Flow ↑6.0% YoY
$1.60M
FCF Yield: 0.81%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: -78.4%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (IPHA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2015
FY 2017 $44.0M $44.0M $-48.0M $-0.1M $-21.5M
FY 2018 $94.0M +113.4% $93.8M $2.7M +105.7% $-0.1M $-117.7M -446.8%
FY 2019 $85.8M -8.7% $85.6M $7.9M +189.5% 0.00% $-0.2M $-1.5M +98.7%
FY 2020 $70.5M -17.9% $70.1M $-0.8M -110.5% 0.00% $-0.3M $-1.2M +15.4%
FY 2021 $24.7M -64.9% $24.4M $-45.5M -5,385.9% 0.00% $-0.3M $-1.2M +0.6%
FY 2022 $57.7M +133.5% $57.4M $-58.0M -27.5% 0.00% $-0.5M +56.9%
FY 2023 $61.6M +6.9% $61.0M $-7.6M +86.9% 0.00% $-0.1M +73.8%
FY 2024 $20.1M -67.4% $19.6M $-49.5M -553.5% 0.00% $1.9M $1.5M +1,177.9%
FY 2025 $9.0M -55.2% $8.6M $-49.2M +0.6% 0.00% $1.8M $1.6M +6.0%
$

Valuation

Market Price $2.11
Market Cap $197.75M
Enterprise Value $192.23M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield 0.81%
Dividend Yield 0.00%
Shares Outstanding 93,719,323
%

Profitability & Margins

Gross Margin 95.12%
Operating Margin -598.89%
Net Margin -545.32%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -78.41%
Asset Turnover 0.14x
Revenue 3-Yr CAGR -46.13%
🛡️

Financial Health & Liquidity

Current Ratio 1.27
Cash Ratio 0.77
Debt / Equity -1.040
Debt / Assets 0.360
Cash & Equivalents $28.09M
Total Debt $22.57M
Book Value / Share $-0.23
💧

Cash Flow Efficiency

Operating Cash Flow $1.80M
Capital Expenditures (CapEx) $201.00K
Free Cash Flow $1.60M
OCF / Revenue 19.96%
FCF / Revenue 17.73%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-0.23
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $62.72M
Total Liabilities $84.42M
Stockholders' Equity -$21.70M
Current Assets $46.71M
Current Liabilities $36.65M